CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Insider Changes in Ownership
- 4 Open-market sale Director sold 920 shares at $12.51 ($11,509)
- 4 Open-market sale Chief Executive Officer sold 15,000 shares at an average $69.36 ($1,040,400)
- 4 Open-market sale President sold 75,000 shares at $60.00 ($4,500,000)
- 4 Open-market sale Director sold 44,000 shares at an average $57.99 ($2,551,440)
- 4 Open-market sale Director sold 44,000 shares at an average $57.99 ($2,551,440)
- 4 Open-market sale Director sold 650,000 shares at an average $54.39 ($35,352,456)
- 4 Other acquisition Director acquired 199 shares (other)
- 4 Open-market sale Director sold 121,362 shares at an average $50.39 ($6,115,873)
- 4 Open-market sale Director sold 128,950 shares at an average $50.39 ($6,497,892)
- 4 Open-market sale Director sold 30,566 shares at an average $50.29 ($1,537,138)
- 4 Open-market sale Director sold 30,566 shares at an average $50.29 ($1,537,138)
- 4 Open-market sale Director sold 222,258 shares at an average $50.11 ($11,136,437)
- 4 Open-market sale Director sold 222,258 shares at an average $50.11 ($11,136,437)
- 4 Open-market sale Director sold 22,841 shares at an average $50.99 ($1,164,655)
- 4 Open-market sale Director sold 22,841 shares at an average $50.99 ($1,164,655)
- 4 Open-market sale 10% owner sold 22,841 shares at an average $50.99 ($1,164,655)
Page 19 of 26 · 502 filings